ENANTA PHARMACEUTICALS INC Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENANTA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ENANTA PHARMACEUTICALS INC for February 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21 2017 | ENTA | ENANTA PHARMACEUTI ... | Russell Lesley | Director | Option Exercise | A | 29.02 | 2,500 | 72,550 | 2,500 | |
| Feb 21 2017 | ENTA | ENANTA PHARMACEUTI ... | Vance Terry | Director | Option Exercise | A | 29.02 | 7,500 | 217,650 | 7,500 | |
| Feb 21 2017 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | A | 29.02 | 7,500 | 217,650 | 7,500 | |
| Feb 21 2017 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Option Exercise | A | 29.02 | 7,500 | 217,650 | 7,500 | |
| Feb 21 2017 | ENTA | ENANTA PHARMACEUTI ... | Buckley Stephen Jr. | Director | Option Exercise | A | 29.02 | 7,500 | 217,650 | 7,500 | |
| Feb 15 2017 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Payment of Exercise | F | 29.82 | 1,079 | 32,170 | 303,717 | 304.8 K to 303.7 K (-0.35 %) |
| Feb 15 2017 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Grant | A | 0.00 | 2,920 | 0 | 304,796 | 301.9 K to 304.8 K (+0.97 %) |
| Feb 15 2017 | ENTA | ENANTA PHARMACEUTI ... | Ocain Tim | Senior Vice Preside ... | Payment of Exercise | F | 29.82 | 830 | 24,746 | 1,370 | 2.2 K to 1.4 K (-37.73 %) |
| Feb 15 2017 | ENTA | ENANTA PHARMACEUTI ... | Ocain Tim | Senior Vice Preside ... | Grant | A | 0.00 | 2,200 | 0 | 2,200 | 0 to 2.2 K |
| Feb 15 2017 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Payment of Exercise | F | 29.82 | 981 | 29,249 | 62,705 | 63.7 K to 62.7 K (-1.54 %) |
| Feb 15 2017 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Grant | A | 0.00 | 2,600 | 0 | 63,686 | 61.1 K to 63.7 K (+4.26 %) |
| Feb 15 2017 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Payment of Exercise | F | 29.82 | 2,278 | 67,919 | 634,821 | 637.1 K to 634.8 K (-0.36 %) |
| Feb 15 2017 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 6,800 | 0 | 637,099 | 630.3 K to 637.1 K (+1.08 %) |
| Feb 15 2017 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Payment of Exercise | F | 29.82 | 830 | 24,746 | 3,270 | 4.1 K to 3.3 K (-20.24 %) |
| Feb 15 2017 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 2,200 | 0 | 4,100 | 1.9 K to 4.1 K (+115.79 %) |
| Feb 15 2017 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Payment of Exercise | F | 29.82 | 792 | 23,613 | 1,308 | 2.1 K to 1.3 K (-37.71 %) |
| Feb 15 2017 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 2,100 | 0 | 2,100 | 0 to 2.1 K |